Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
6.01
+0.31 (5.44%)
At close: Jun 6, 2025, 4:00 PM
5.80
-0.21 (-3.49%)
After-hours: Jun 6, 2025, 7:17 PM EDT
Jasper Therapeutics Market Cap
Jasper Therapeutics has a market cap or net worth of $90.28 million as of June 6, 2025. Its market cap has decreased by -74.09% in one year.
Market Cap
90.28M
Enterprise Value
44.07M
1-Year Change
-74.09%
Ranking
Category
Stock Price
$6.01
Market Cap Chart
Since January 10, 2020, Jasper Therapeutics's market cap has decreased from $122.75M to $90.28M, a decrease of -26.45%. That is a compound annual growth rate of -5.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 90.28M | -71.85% |
| Dec 31, 2024 | 320.73M | 264.33% |
| Dec 29, 2023 | 88.03M | 294.73% |
| Dec 30, 2022 | 22.30M | -94.26% |
| Dec 31, 2021 | 388.71M | 210.66% |
| Dec 31, 2020 | 125.13M | 1.93% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 688.56B |
| Johnson & Johnson | 372.24B |
| AbbVie | 335.19B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 271.24B |
| Abbott Laboratories | 232.95B |
| Novartis AG | 230.96B |
| AstraZeneca | 225.55B |